India's coronavirus vaccine supply jumps, raising hopes of export
India's rising output of Covid-19
vaccines and the inoculation of more than half its adult population
with at least one dose are raising hopes the country will return as an exporter
within months, ramping up from early next year.
After donating or selling 66 million doses
to nearly 100 countries, India barred exports in the middle of April to focus
on domestic immunisation as infections exploded, upsetting the inoculation
plans of many African and South Asian countries.
India's daily vaccinations surpassed 10
million doses on Friday, with national vaccine production more than doubling
since April and set to rise again in the coming weeks. New production lines
have been set up, a vaccine developed by Cadila Healthcare won recent approval,
and commercial production of Russia's Sputnik V is starting in India.
The Serum Institute of India (SII), the
world's biggest vaccine maker, is now producing about 150 million doses a month
of its version of the AstraZeneca shot, more than twice its April output of
about 65 million, a source with knowledge of the matter said.
Comments
Post a Comment